What to expect when you take Lessina-21 and have Fibrillary glomerulonephritis?

Do you take Lessina-21 and have Fibrillary glomerulonephritis? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 19, 2018

299 reports have been studied.


Females aged 50 to 59 :

299 related reports were analyzed:

Most common symptoms:

Breast cancer
  • 5.35% for females aged 50 (±5) who take Lessina-21
Chest pain
  • 7.36% for females aged 50 (±5) who take Lessina-21
Fatigue (feeling of tiredness)
  • 5.02% for females aged 50 (±5) who take Lessina-21
Nausea (feeling of having an urge to vomit)
  • 10.03% for females aged 50 (±5) who take Lessina-21
Pulmonary embolism (blockage of the main artery of the lung)
  • 7.02% for females aged 50 (±5) who take Lessina-21
Weakness
  • 5.02% for females aged 50 (±5) who take Lessina-21

Most common co-existing conditions:

Birth control
  • 16.72% for females aged 50 (±5) who take Lessina-21
Depression
  • 5.35% for females aged 50 (±5) who take Lessina-21
Hormone replacement therapy
  • 6.02% for females aged 50 (±5) who take Lessina-21
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 7.36% for females aged 50 (±5) who take Lessina-21
back to top

Males aged 50 to 59 :

0 related reports were analyzed:

Most common symptoms:

  • n/a

Most common co-existing conditions:

  • n/a
back to top

Related studies

lessina-21

Lessina-21 has active ingredients of ethinyl estradiol; levonorgestrel. (latest outcomes from Lessina-21 5 users)

fibrillary glomerulonephritis

Fibrillary glomerulonephritis (progressive renal dysfunction with deposit in glomeruli) has been reported by people with systemic lupus erythematosus, high blood pressure, hot flush, primary myelofibrosis, high blood cholesterol (latest reports from 29 Fibrillary glomerulonephritis patients).

Lessina-21 and Fibrillary glomerulonephritis

Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Lessina-21, Fibrillary glomerulonephritis

Recent updates

General studies
Active Support Groups
Recent Care Guides

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.